Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Acasti Pharma 10% Owner Vimal Kavuru Reported Purchase Of 1,099,103 Shares @ Avg Price: Of $1.19/Share In Form 4 Filing On Wednesday

Author: Charles Gross | September 28, 2023 05:22am

Posted In: ACST